2022
DOI: 10.1007/s11051-022-05403-9
|View full text |Cite
|
Sign up to set email alerts
|

The technology for improving stability of nanosuspensions in drug delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 161 publications
0
8
0
Order By: Relevance
“…In these methods, the nanoparticulate systems are separated from the release medium through dialysis membranes that are permeable to the free drug but impermeable to the nanoparticles. Dialysis methods have been widely used to investigate in vitro drug dissolution/release profiles of liposomes [ 29 , 30 ], emulsions [ 31 ], polymeric nanoparticles [ 32 , 33 ], as well as lipid nanocarriers [ 34 ].…”
Section: Resultsmentioning
confidence: 99%
“…In these methods, the nanoparticulate systems are separated from the release medium through dialysis membranes that are permeable to the free drug but impermeable to the nanoparticles. Dialysis methods have been widely used to investigate in vitro drug dissolution/release profiles of liposomes [ 29 , 30 ], emulsions [ 31 ], polymeric nanoparticles [ 32 , 33 ], as well as lipid nanocarriers [ 34 ].…”
Section: Resultsmentioning
confidence: 99%
“…However, this does not change the saturation solubility of a drug, and low oral bioavailability still poses a problem [ 67 ]. Although it is known that the saturation solubility of an active substance is a compound-specific property depending on crystalline form, the lipophilicity of the drug, fed/fasted state, pKa, temperature, and properties of dissolution medium, at a nanometer range of saturation solubility, are also functions of particle size, according to the Ostwald–Freundlich and Kelvin equations [ 16 , 68 , 69 ]. NSs provide a tremendous increase in the surface-area-to-volume ratio and this leads to a higher solubility.…”
Section: Administration Routes Of Nanosuspensionsmentioning
confidence: 99%
“…Nanosuspensions have some drawbacks which include long-term physical and chemical instability resulting in short shelf life periods. Also, nanosuspensions produced by liquid AS crystallization tend to have low API concentrations and, thus, may require large dose volumes to achieve an effective dose. Thus, separating nanoparticles from suspension into a dry powder form is often desired but is not without its challenges due to slow filtration rates and particle growth or agglomeration during separation.…”
Section: Introductionmentioning
confidence: 99%
“…Nanosuspensions have some drawbacks which include longterm physical and chemical instability 26 resulting in short shelf life periods. 26−29 Also, nanosuspensions produced by liquid AS crystallization tend to have low API concentrations and, thus, may require large dose volumes to achieve an effective dose.…”
Section: Introductionmentioning
confidence: 99%